Revolution Medicines Reports Second Quarter 2022 Financial Results and Update on Corporate Progress

Go back to Revolution Medicines Reports Second Quarter 2022 Financial Results and Update on Corporate Progress
(NASDAQ: RVMD) Delayed: 207.68 +0.36 (0.17%)
Previous Close $207.32    52 Week High
Open $206.01    52 Week Low
Day High $213.00    P/E N/A 
Day Low $204.46    EPS
Volume 1,227,158